Study period | ||||||
---|---|---|---|---|---|---|
Enrolment | Randomisation | Post randomisation | ||||
Timepoint | -T | T = 0 | Hospitalisation | T < week 2 | T + 30 day | T + 1 year |
Enrolment | ||||||
Inclusion criteria | X | |||||
Exclusion criteria | X | |||||
Allocation | X | |||||
Informed consent | X | X | ||||
Interventions | ||||||
Intervention or control group | X | |||||
Assessments | ||||||
ROSC | X | |||||
Survival | X | X | X | X | X | |
Pre-hospital registrations | ||||||
Utstein styled documentation | X | X | ||||
End-tidal CO2 | X | |||||
REBOA-procedure related data | X | |||||
All relevant dispatch/procedure times | X | X | X | |||
In-hospital registrations | ||||||
Blood gas from admission | X | |||||
Blood sample analysis | X | X | ||||
Urine output | X | X | ||||
Complications related to REBOA | X | X | X | |||
Cardiac interventions | X | X | X | |||
Length of stay intensive care | X | X | X | |||
Length of stay hospital | X | X | X | |||
Length of invasive respiratory support | X | X | X | |||
Length of renal replacement therapy | X | X | X | |||
Modified Rankin scale | X | |||||
Adverse events | X | X | X | X |